Patent · US Active

Abiraterone acetate lipid formulations

US10722527B2 · kind B2 · utility

0Cited by

31References

15Claims

0Family size

Assignee

Capsugel Belgium NV · BE

Inventors

Hywel Williams · Mona Vale, AU
Prashant Agarwal · Grafton, GB
Eduardo Jule · Ekeren, BE

Key dates

Filing date	Mar 25, 2016
Grant date	Jul 28, 2020
Priority date	—
Expiry date	Mar 25, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J43/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Abiraterone acetate lipid formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.